Xingfei Pan

1.5k total citations
36 papers, 385 citations indexed

About

Xingfei Pan is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Xingfei Pan has authored 36 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 11 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Xingfei Pan's work include Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xingfei Pan is often cited by papers focused on Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xingfei Pan collaborates with scholars based in China, United States and Canada. Xingfei Pan's co-authors include Yunjiao Zhou, Hong Cao, Peishan Qiu, Jing Liu, Haizhou Wang, Fan Wang, Qiu Zhao, Meng Zhang, Jianxi Lu and Xin Shu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Xingfei Pan

33 papers receiving 376 citations

Peers

Xingfei Pan
Xingfei Pan
Citations per year, relative to Xingfei Pan Xingfei Pan (= 1×) peers José Miguel Urra

Countries citing papers authored by Xingfei Pan

Since Specialization
Citations

This map shows the geographic impact of Xingfei Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingfei Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingfei Pan more than expected).

Fields of papers citing papers by Xingfei Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingfei Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingfei Pan. The network helps show where Xingfei Pan may publish in the future.

Co-authorship network of co-authors of Xingfei Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xingfei Pan. A scholar is included among the top collaborators of Xingfei Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingfei Pan. Xingfei Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Xingfei, et al.. (2025). sFlt ‐1/ PlGF ratio thresholds for diagnosing pre‐eclampsia in pregnant women with high blood pressure. Ultrasound in Obstetrics and Gynecology. 66(5). 631–640.
2.
Pan, Xingfei, Liyang Zhou, Panpan Zhai, et al.. (2025). Tenofovir Alafenamide Therapy Throughout Pregnancy in Mothers With Hepatitis B. Alimentary Pharmacology & Therapeutics. 62(2). 159–167.
3.
Liu, Lin, Wei Xiao, Yumei Gong, et al.. (2024). Characteristics of splenic PD-1+ γδT cells in Plasmodium yoelii nigeriensis infection. Immunologic Research. 72(3). 383–394. 1 indexed citations
4.
Zhou, Liyang, et al.. (2024). Chronic Hepatitis B in Women of Childbearing Age and Pregnant Women in China: A Cross-Sectional Study. American Journal of Tropical Medicine and Hygiene. 110(4). 719–723. 1 indexed citations
5.
He, Wenyin, Ying Yuan, Junyu Liang, et al.. (2023). Detection of macrolide and fluoroquinolone resistance-associated 23S rRNA and parC mutations in Mycoplasma genitalium by nested real-time PCR. Frontiers in Cellular and Infection Microbiology. 13. 1271392–1271392. 1 indexed citations
6.
Liang, Dan, Mingxing Huang, Li Wang, et al.. (2022). Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum. Pathogens. 11(12). 1531–1531. 3 indexed citations
7.
Wei, Haixia, Jiajie Li, Chao Fang, et al.. (2022). PD-1+ CD4 T cell immune response is mediated by HIF-1α/NFATc1 pathway after P. yoelii infection. Frontiers in Immunology. 13. 942862–942862. 8 indexed citations
8.
Zhou, Xiaoqi, Guangming Ye, Yibing Lv, et al.. (2022). IL-6 drives T cell death to participate in lymphopenia in COVID-19. International Immunopharmacology. 111. 109132–109132. 8 indexed citations
9.
Li, Xuan, Liyang Zhou, Lina Zhang, et al.. (2021). The combined regimens of antiviral therapy might not be useful for the viral clearance of severe COVID-19 cases. Journal of Infection and Public Health. 14(11). 1693–1700. 2 indexed citations
10.
Feng, Yuanfa, Hongyan Xie, Jiajie Li, et al.. (2021). Roles of TLR7 in Schistosoma japonicum Infection-Induced Hepatic Pathological Changes in C57BL/6 Mice. Frontiers in Cellular and Infection Microbiology. 11. 754299–754299. 2 indexed citations
11.
Qiu, Peishan, Yunjiao Zhou, Fan Wang, et al.. (2020). Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clinical and Experimental Research. 32(9). 1869–1878. 87 indexed citations
12.
Pan, Xingfei, Hong Cao, Xin Shu, et al.. (2017). IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs. Experimental and Therapeutic Medicine. 14(4). 3880–3886. 7 indexed citations
13.
Xu, Haixia, Shaoquan Zhang, Xingfei Pan, et al.. (2016). TIMP-1 expression induced by IL-32 is mediated through activation of AP-1 signal pathway. International Immunopharmacology. 38. 233–237. 12 indexed citations
14.
Pan, Xingfei, et al.. (2016). Human hepatocytes express absent in melanoma 2 and respond to hepatitis B virus with interleukin-18 expression. Virus Genes. 52(4). 445–452. 17 indexed citations
15.
Zou, Yong, Junjie Bao, Xingfei Pan, et al.. (2015). NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. PLoS ONE. 10(8). e0134568–e0134568. 15 indexed citations
16.
Pan, Xingfei, Ka Zhang, Xuejun Li, et al.. (2013). Relapse Rate and Associated-Factor of Recurrence after Stopping NUCs Therapy with Different Prolonged Consolidation Therapy in HBeAg Positive CHB Patients. PLoS ONE. 8(7). e68568–e68568. 21 indexed citations
17.
Zhang, Ka, Xingfei Pan, Xin Shu, et al.. (2013). Relationship between MIF-173 G/C polymorphism and susceptibility to chronic hepatitis B and HBV-induced liver cirrhosis. Cellular Immunology. 282(2). 113–116. 13 indexed citations
18.
Li, Xueling, Hong Cao, Biao Di, et al.. (2012). Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice. Microbes and Infection. 14(11). 1000–1007. 21 indexed citations
19.
Pan, Xingfei, Xin Shu, Hong Cao, et al.. (2012). Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. Journal of Infection. 65(4). 336–342. 30 indexed citations
20.
Pan, Xingfei, Hong Cao, Jianxi Lu, et al.. (2011). Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB. Molecular Immunology. 48(12-13). 1573–1577. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026